203 related articles for article (PubMed ID: 17499300)
1. Malignant ureteral obstruction: outcomes after intervention. Have things changed?
Wong LM; Cleeve LK; Milner AD; Pitman AG
J Urol; 2007 Jul; 178(1):178-83; discussion 183. PubMed ID: 17499300
[TBL] [Abstract][Full Text] [Related]
2. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
3. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.
Kouba E; Wallen EM; Pruthi RS
J Urol; 2008 Aug; 180(2):444-50. PubMed ID: 18550089
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in malignant ureteric obstruction.
Lienert A; Ing A; Mark S
BJU Int; 2009 Oct; 104(7):938-41. PubMed ID: 19338533
[TBL] [Abstract][Full Text] [Related]
5. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
6. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction.
Izumi K; Mizokami A; Maeda Y; Koh E; Namiki M
J Urol; 2011 Feb; 185(2):556-61. PubMed ID: 21168872
[TBL] [Abstract][Full Text] [Related]
7. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
8. The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.
Jeong IG; Han KS; Joung JY; Seo HK; Chung J
BJU Int; 2007 Dec; 100(6):1288-91. PubMed ID: 17850371
[TBL] [Abstract][Full Text] [Related]
9. Use of nephrostomy tubes in ureteric obstruction from incurable malignancy.
Little B; Ho KJ; Gawley S; Young M
Int J Clin Pract; 2003 Apr; 57(3):180-1. PubMed ID: 12723719
[TBL] [Abstract][Full Text] [Related]
10. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
11. Outcome analysis and cost comparison between externalized pyeloureteral and standard stents in 470 consecutive open pyeloplasties.
Braga LH; Lorenzo AJ; Farhat WA; Bägli DJ; Khoury AE; Pippi Salle JL
J Urol; 2008 Oct; 180(4 Suppl):1693-8; discussion1698-9. PubMed ID: 18708220
[TBL] [Abstract][Full Text] [Related]
12. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
[TBL] [Abstract][Full Text] [Related]
13. Combined arterial infusion and stent implantation compared with metal stent alone in treatment of malignant gastroduodenal obstruction.
Wang Z; Chen K; Gong J; Zheng Y; Wang T
Cardiovasc Intervent Radiol; 2009 Sep; 32(5):1011-8. PubMed ID: 19669831
[TBL] [Abstract][Full Text] [Related]
14. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi.
Pearle MS; Pierce HL; Miller GL; Summa JA; Mutz JM; Petty BA; Roehrborn CG; Kryger JV; Nakada SY
J Urol; 1998 Oct; 160(4):1260-4. PubMed ID: 9751331
[TBL] [Abstract][Full Text] [Related]
15. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
16. Parallel second stent placement for refractory ureteral stent malfunction in malignant ureteral obstruction.
Chen HC; Shen SH; Wang JH; Huang WJ; Tseng HS; Chang PY; Chang CY
J Vasc Interv Radiol; 2011 Jul; 22(7):1012-6. PubMed ID: 21571544
[TBL] [Abstract][Full Text] [Related]
17. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
Trivanović D; Petkovic M; Stimac D
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
[TBL] [Abstract][Full Text] [Related]
18. Management of extrinsic malignant ureteral obstruction with urinary diversion.
Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous nephrostomy in malignant ureteral obstruction].
Demetriou D; Sebeikat D
Dtsch Med Wochenschr; 1996 Dec; 121(49):1526-30. PubMed ID: 8998920
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of ureteral stenting for managing extrinsic ureteral obstruction due to gynecological and gastrointestinal cancer].
Takehara K; Onita T; Mochizuki Y; Miyata Y; Igawa T; Sakai H
Hinyokika Kiyo; 2014 Jan; 60(1):13-6. PubMed ID: 24594767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
